Eldridge Investment Advisors’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-25,147
| Closed | -$2.25M | – | 152 |
|
|
2023
Q4 | $2.25M | Sell |
25,147
-1,765
| -7% | -$158K | 0.59% | 40 |
|
|
2023
Q3 | $1.97M | Sell |
26,912
-53
| -0.2% | -$3.87K | 0.65% | 31 |
|
|
2023
Q2 | $2.24M | Sell |
26,965
-2,396
| -8% | -$199K | 0.73% | 32 |
|
|
2023
Q1 | $2.24M | Sell |
29,361
-523
| -2% | -$39.9K | 0.78% | 30 |
|
|
2022
Q4 | $2.48M | Buy |
29,884
+1,339
| +5% | +$111K | 0.87% | 27 |
|
|
2022
Q3 | $2.26M | Sell |
28,545
-26,104
| -48% | -$2.07M | 0.88% | 25 |
|
|
2022
Q2 | $4.06M | Buy |
+54,649
| New | +$4.06M | 1.53% | 18 |
|